.jpg)
Symposium on New Methodology for Clinical Trials in Rare Diseases
Asterix End Symposium - 18 & 19 September 2017, Zaandam (the Netherlands)
General Information
The final symposium of the EU FP 7 funded Asterix project is an open, interactive conference on innovation of clinical trial methodology for rare diseases. Its objectives are:
-
To share the progress made to advance clinical trial methodology, in the interest of developing new treatments for patients suffering from a rare disease.
-
To share and illustrate proven and potential impact on clinical trials, with a special focus on drug development and regulation.
-
To stimulate further implementation and continued development of methodology.
The symposium will follow the approach that is also part of the project: involving and integrating the views of patients, regulators and clinical researchers. Asterix is in its final year and is currently busy organizing its final symposium.
Registration is open - see below (please book your hotel separately - see below)
Audience
The target audience is wide: Statisticians and (clinical) researchers working in the field of small populations, patient representatives and all others interested in new methodology for clinical trials for rare diseases.
Program & Sessions
The sessions generally focus on one of the broader areas that have the potential to improve the design, analysis and interpretation of clinical trials. Each session will cover topics from a methodological, clinical and patient perspective. Innovations will further be illustrated against regulatory experience of orphan drug approvals over the past 15 years. Throughout the Asterix proposed clustering of conditions will be used to aid practical guidance for application of the proposed methods.
More details on the program and an overview of confirmed speakers can be be found here.
Poster sessions
If you plan to attend our conference, please consider creating a poster for display at the conference venue during designated times for poster presenters on Tuesday September 19.
Posters should relate to innovation of clinical trial methodology for rare diseases. All presenters must be registered as participant by the registration process. Abstracts should be received before September 1, 2017 at endsymposium.asterix@amc.uva.nl. Applicants will be informed before September 8, 2017.
Please find here the abstract instruction (max 200 words). Poster guidance can be found at the links below.
Date and Venue
Our Symposium will take place in the Inntel Hotel in Zaandam, the Netherlands, and will start on Monday September 18th, 1.00 pm with a joint reception at the end of the day. After the reception a joint dinner (optional, Costs € 42,-) is organized from 7.00 pm until 10.00 pm. On Tuesday September 19th our symposium will end around 5.00 pm.
Conference Fee
Symposium costs including lunch & refreshments is €300 for industry, €225 for academics, and €100 for patient representatitves.
Hotels
Two hotels have provided a room contingent for the guests of our Symposium. We recommend you to book a hotel room at your earliest convenience. Please use the links below.
Links
REGISTRATION IS NOW OPEN:
(registration doesn't include hotel booking - please book it separately)
Book your hotel room(s). Links available till August 6th:
-
Inntel hotel Zaandam (Venue Symposium) – 1 adult - € 157,00 incl. breakfast
-
Zaan Inn hotel (8 minutes’ walk to Venue- see link) – 1 adult - € 140.00/145,00 incl. breakfast
Route Zaan inn hotel – Inntel hotel (venue)
Download the flyer to advertise the Symposium
Program and confirmed speakers
